Amgen, Inc.

Dividend yield
Dividend has grown by 12.34% in last three years.
2.83 %
$6.1 anually
P/E ratio
Payout ratio
Proportion of net income paid out as dividends to shareholders
Company profitability (EPS)
past 12 months
CASH payout ratio
Amgen, Inc. last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile AMGN stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Amgen, Inc. have in comparison to other dividend stocks
Become our supporter to unlock all data!
Amgen, Inc. description

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K.

Bowes, Jr., Franklin Pitcher Johnson, Jr., George B.

Company profile
Market cap
Mega (133.20B)
Company CEO
Robert A. Bradway
Price history Amgen, Inc.
Loading price stock history...
AMGN dividends payouts
Similar stocks as Amgen, Inc.